Connecticut's complex justice issues, unpacked

Get CT Mirror emails in your inbox daily.

Processing…
Success! You're on the list.

In-depth journalism.
In your home state.
In your inbox.

Sign up for CT Mirror's free daily briefings.

Processing…
Success! You're on the list.
Posted inHealth

Jepsen sues Purdue, saying it reaped profits by boosting opioid addiction

Connecticut became the latest state on Thursday to sue Stamford-based Purdue Pharma, saying the company purposefully downplayed the risks of addiction of OxyContin and other opioid painkillers. Connecticut Attorney General George Jepsen said he sued in Superior Court because Purdue was not “serious about addressing the states’ very real allegations of misconduct and coming to a meaningful settlement.”

Posted inHealth

CT opioid lawsuits advancing in face of settlement effort

WASHINGTON — Nearly two dozen Connecticut cities and towns are scheduled to soon confront Purdue Phama and other opioid makers in court over what they say are the pharmaceuticals’ deceptive practices. Meanwhile, there is an effort by a federal judge in Ohio to negotiate a massive settlement for the hundreds of federal lawsuits across the nation targeting the opioid makers for their marketing practices.

Posted inHealth, Justice

Growing number of states press opioid suits against Stamford’s Purdue Pharma

Updated at 10:15 a.m. with industry comment 
WASHINGTON — Stamford-based Purdue Pharma, the maker of pain-killer OxyContin, is the target of an increasing number of suits by states, counties and cities alleging it is partly to blame for the nation’s opioid epidemic. The lawsuits are all different and some include other pharmaceutical companies and pharmacies as defendants. But Purdue is nearly always a main defendant.